ReviewClinical pharmacology and therapeutics2026
Discontinuing Long-Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
Ko-Hsiu Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it